Navigation Links
TargetEx Leads the European Cancer Research Consortium
Date:10/9/2009

BUDAPEST, Hungary, October 9 /PRNewswire/ -- TargetEx llc, Budapest announced today that the Research Directorate General of the Commission of the European Communities approved the transfer of the coordinator responsibilities of the European Cancer Research Consortium (CancerGrid) to TargetEx.

"This is very important for TargetEx" -an emerging biotech company in Hungary - "and an appreciation of our scientific potential " said Sandor Cseh, PhD., managing director. "We are excited to lead the consortium in the remaining phase of the project and we look forward to the exploitation of the exciting results and experience gathered in the effort of developing novel technologies and agents for cancer therapy."

"The CancerGrid consortium is an excellent combination of 11 European research-oriented companies and academic centers integrating their best practices and specific knowledge including AMRI (USA/Hungary), Inte:Ligand (Austria), Tallinn University of Technology (Estonia), University of Helsinki (Finland), GKI Economic Research Co.(Hungary), Computer and Automation Research Institute (Hungary), DAC Srl and University of Bari (Italy), University Pompeu Fabra (Spain) and Hebrew University of Jerusalem (Israel)" added Istvan Bagyi, PhD., the project coordinator of CancerGrid.

Cancer is one of the major causes of death worldwide and developing successful therapies is particularly challenging due to the high variability of cells, oncogenes and mutations. Developing tumor-cell specific cytotoxic agents is not only one of the aims of the CancerGrid project but also a "gentle" approache since they will attack only the cancer cells while not affecting the healthy cellular functions.

"The primary objective of the multidisciplinary FP6 project is to integrate various state-of-the art technologies including TargetEx' high-throughput differential cytotoxicity screening platform; in si
'/>"/>

SOURCE Targetex Ltd
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. UCSF researchers help crack parasite genome, identify drug leads
2. Debiopharm and Pharmaleads Sign License Agreement for Debio 0827 or PL37 in Treatment of Chronic Pain Conditions
3. LightLab Imaging Leads Global Advancement of Intracoronary Imaging
4. Plexon Inc Delivers 500th "Harvey Box" : 25 Years of Neural Data Acquisition and Analysis Leads to 500th System Sale
5. Incorrectly cleaved protein leads to schizophrenia
6. Aegera Therapeutics collaboration with Human Genome Sciences leads to the initiation of a Phase 1 clinical trial with lead IAP inhibitor HGS1029 and receipt of first milestone payment
7. Paul Capital Healthcare Leads Panel on Strategic Financing
8. Microsurgery on the brain of the fruit fly leads to new insights into irreparable nerve injuries
9. Increased Drug Related Cardiac Toxicity Leads Gwathmey Preclinical Testing Services to Create Novel Cardionomics(TM) Services for Preclinical Cardiac Safety Screening of Drug Candidates
10. Increased Light Leads to Early Detection: Caliper Life Sciences Introduces Bioware(R) Ultra Cancer Cell Lines
11. Purdue leads center to simulate behavior of micro-electromechanical systems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... -- Research and Markets has announced the ... & Reagents (Cloning, Epigenetics, PCR, Restriction Digestion, Sequencing) Market ... The global molecular biology enzymes market ... expected to grow at a CAGR of 13.74% to ... & reagents find applications in a large number of ...
(Date:8/22/2014)... Angeles (PRWEB) August 22, 2014 ... age-defying products, is in the spotlight again. Nerium ... cream and its NeriumFirmTM Body Contouring Cream to ... by Backstage Creations during the 66th Primetime Emmy® ... patented NAE-8® extract, third-party clinical trials show that ...
(Date:8/22/2014)... “Our nation's healthcare system is broken, ... Furthermore, every governmental and professional entity that has ... of unorganized dysfunction shares in that enormous blame. ... as a device to use in an effort ... have accumulated through the years leading to the ...
(Date:8/21/2014)... PA & Rockville, MD (PRWEB) August 21, 2014 ... (ITI) is making progress in its development of ... to Japanese red cedar pollen. Phase IC studies began ... a real solution to hay fever. , The Japanese ... over 35 million people in Japan. Mountain Cedar pollen ...
Breaking Biology Technology:Global Molecular Biology Enzymes, Kits, & Reagents (Cloning, Epigenetics, PCR, Restriction Digestion, Sequencing) Market - Forecast to 2018 2Global Molecular Biology Enzymes, Kits, & Reagents (Cloning, Epigenetics, PCR, Restriction Digestion, Sequencing) Market - Forecast to 2018 3Nerium International Joins Television’s Biggest Stars at Backstage Creations Giving Suite at the 66th Primetime Emmy Awards 2Nerium International Joins Television’s Biggest Stars at Backstage Creations Giving Suite at the 66th Primetime Emmy Awards 35 Great Mistakes in Healthcare and How to Fix Them by Dr. Ira Williams 2Relief for Allergy Sufferers Finally in Sight: Immunomic Therapeutics Closes in on Treatment for Hay Fever in Japan, U.S. 2Relief for Allergy Sufferers Finally in Sight: Immunomic Therapeutics Closes in on Treatment for Hay Fever in Japan, U.S. 3Relief for Allergy Sufferers Finally in Sight: Immunomic Therapeutics Closes in on Treatment for Hay Fever in Japan, U.S. 4
... Combination of Panzem(R) NCD and Avastin(R) May ... 28 EntreMed, Inc.,(Nasdaq: ENMD ), ... treatment of cancer and inflammatory diseases, today,announced ... Phase 2 multi-center,study combining Panzem(R) NCD with ...
... PARIS, January 28 Sanofi-aventis announced,today that ... approved for marketing in Japan by the ... prevention of venous thromboembolism (VTE) in patients,undergoing ... as total hip,replacement, total knee replacement and ...
... Inc.,(NYSE: FRX ), Forest Laboratories Holdings, Ltd., ... GmbH announced that they have filed a second,lawsuit ... of Delaware against,additional companies for infringement of U.S. ... Forest,s Namenda(R) product. The defendants,named in the lawsuit ...
Cached Biology Technology:EntreMed Presents Interim Results for Phase 2 Carcinoid Tumor Study 2EntreMed Presents Interim Results for Phase 2 Carcinoid Tumor Study 3EntreMed Presents Interim Results for Phase 2 Carcinoid Tumor Study 4Clexane(R)/Lovenox(R) Approved in Japan 2Clexane(R)/Lovenox(R) Approved in Japan 3Clexane(R)/Lovenox(R) Approved in Japan 4Clexane(R)/Lovenox(R) Approved in Japan 5Forest Laboratories, Inc. and Merz Pharma GmbH & Co. KgaA File Additional Lawsuit Against Several Companies for Patent Infringement 2
(Date:8/22/2014)... tea polyphenols are strong antioxidants and can ... spinal cord neurons against oxidative stress? Jianbo ... Hospital of Liaoning Medical University, China discovered ... stress and inhibit neuronal apoptosis, indicating green ... spinal cord neurons under oxidative stress. The ...
(Date:8/22/2014)... American consumers will finally be able to purchase fuel ... as zero-emissions vehicles, most of the cars will run ... that contributes to global warming. , Now scientists at ... uses an ordinary AAA battery to produce hydrogen by ... through two electrodes that split liquid water into hydrogen ...
(Date:8/21/2014)... Ga. An international team of scientists including researchers from ... Brassica napus commonly known as canolain the journal Science ... the plant, which is used widely in farming and industry. ... its native Europe, but the winter crop is increasingly cultivated ... its naturally low levels of saturated fat and rich supply ...
Breaking Biology News(10 mins):Stanford scientists develop a water splitter that runs on an ordinary AAA battery 2Stanford scientists develop a water splitter that runs on an ordinary AAA battery 3Canola genome sequence reveals evolutionary 'love triangle' 2
... HUNTSVILLE, TX (Feb. 21, 2012)-- An assistant ... Criminal Justice is working to unlock the mysteries ... play on criminal and antisocial behavior. "Biosocial ... behavior," said Dr. Brian Boutwell. "It involves aspects ...
... 2012A team of researchers has found a way to ... to be available, despite the potential attack of Xylella ... poses a significant threat to the California wine industry,s ... Laboratory (LANL), University of California at Davis (UCD), and ...
... prospective study of ethnic differences in the symptoms of ... background have more delayed language, communication and gross motor ... the Kennedy Krieger Institute concluded that subtle developmental delays ... severe symptoms develop. While the prevalence of autism ...
Cached Biology News:Are there biosocial origins for antisocial behavior? 2More grapes, less wrath: Hybrid antimicrobial protein protects grapevines from pathogen 2New study shows minority toddlers with autism are more delayed than affected Caucasian peers 2New study shows minority toddlers with autism are more delayed than affected Caucasian peers 3
... Tissue Array (MSTA) slides were designed to study ... from multiple species. Tissue slices from three ... which can then be treated as a single ... in situ hybridization. This format allows ...
... Clear yellow solution. In ... thimerosal, and other proprietary ... Diluent formulated to stabilize ... antibody conjugates at high ...
... used to predict the melting ... up to 3,200 bases, which ... primers and GC clamps for ... gel electrophoresis (DGGE), constant denaturing ...
... Mini-Sub cell GT cell and PowerPac basic power ... of nucleic acids in agarose gels. The Mini-Sub ... with cables and electrodes, a 7 x 7 ... casting gates, and two 1.5 mm fixed-height combs ...
Biology Products: